... subject to conditions, the proposed acquisition by Loihde Oyj of BLC Turva Oy ... FCCA opens in-depht investigation into Loihde's proposed acquisition of BLC Turva Loihde Oyj / BLC Turva Oy (in Finnish).
The results of that analysis demonstrated that BLC is cost-effective versus NBI, when assessed over the remaining lifetime of the patient ... instance showed that BLC is cost effective compared to NBI.